Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
IU Simon Cancer Center's Tissue Bank Collecting Samples Sept. 20 At Clarian North
http://www.medicalnewstoday.com/articles/120095.php
Would you like to contribute to breast cancer research?You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 9 a.m. to 2 p.
----------------------------------------------
** CANCER / ONCOLOGY News **
Link Between Nationality And Cervical Cancer
http://www.medicalnewstoday.com/articles/120131.php
Gynaecological screening tests for cervical cancer have been available to all women in Sweden for almost four decades. Despite this, many immigrant women have a higher risk of developing the disease than Swedish-born women, according to a new study from the Swedish medical university Karolinska Institutet.
Rates Of Oesophageal Cancer In UK Among The Worst In Europe
http://www.medicalnewstoday.com/articles/120109.php
Call for national research study to investigate the causes of oesophageal cancerThe Barrett's Oesophagus Foundation would like to support the Chief Medical Officer's recommendation for a large scale national research study to investigate the risk factors associated with the rising rate of cancer of the oesophagus.
Ezetimibe And Cancer Link Still Not Clear Say Experts
http://www.medicalnewstoday.com/articles/120102.php
The link between cholesterol-lowering drug ezetimibe (marketed as Vytorin) and cancer is still not clear, wrote the editors of the leading medical journal <i>New England Journal of Medicine (NEJM)</i>.
Brain Cancer Patients Treated Using Fast And Efficient RapidArc Radiotherapy Technology From Varian Medical Systems
http://www.medicalnewstoday.com/articles/120097.php
Two leading cancer centers have carried out groundbreaking radiosurgery treatments for multiple brain metastases using new RapidArc radiotherapy technology from Varian Medical Systems (NYSE:VAR).
IU Simon Cancer Center's Tissue Bank Collecting Samples Sept. 20 At Clarian North
http://www.medicalnewstoday.com/articles/120095.php
Would you like to contribute to breast cancer research?You can help by donating a tissue sample to the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center from 9 a.m. to 2 p.
'Tanorexia' Common Among University Students According To Survey
http://www.medicalnewstoday.com/articles/120087.php
A new study conducted at a large university finds more than 25 percent of those surveyed reported symptoms of tanning dependence, including symptoms similar to alcohol and drug-addicted individuals.
How Research Is Tackling Cancer: Free Public Lecture In Newcastle
http://www.medicalnewstoday.com/articles/120086.php
Cancer touches many people, but few have the chance to meet the researchers who have dedicated their lives to tackling the disease.This month two world renowned cancer researchers will give a free public lecture in Newcastle to explain how their research is contributing to a better understanding of cancer and more effective treatments.
New Discovery About Growth Factor Can Be Breakthrough For Cancer Research
http://www.medicalnewstoday.com/articles/120028.php
A research team at the Ludwig Institute and Uppsala University has discovered an entirely new signal path for a growth factor that is of crucial importance for the survival and growth of cancer cells.
Potential To Prevent Recurrence Of Bladder Tumors After Surgical Removal Of Upper Urinary Tract Transitional Cell Carcinoma
http://www.medicalnewstoday.com/articles/120024.php
UroToday.com - In this article from the International Journal of Urology, the authors evaluated the survival benefit and prevention of bladder cancer recurrence with adjuvant platinum based chemotherapy, in upper urinary tract urothelial cancer, following surgical resection.
Debiopharm And EPFL Sign Research Project Agreement To Identify Inhibitors Of Signalling Pathways Controlling Cell Fate For Cancer Treatment
http://www.medicalnewstoday.com/articles/120012.php
Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, announced the signature of a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Link Between Nationality And Cervical Cancer
http://www.medicalnewstoday.com/articles/120131.php
Gynaecological screening tests for cervical cancer have been available to all women in Sweden for almost four decades. Despite this, many immigrant women have a higher risk of developing the disease than Swedish-born women, according to a new study from the Swedish medical university Karolinska Institutet.
HPV Vaccine Deemed Safe Despite Higher Anaphylaxis Rates
http://www.medicalnewstoday.com/articles/120032.php
According to a study published in <i>CMAJ</i>, young womenwho had human papillomavirus (HPV) vaccination were found to be five totwenty times more likely to have anaphylaxis than women identified incomparable school-basedvaccination programs.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
Moffitt Cancer Center Receives Prestigious SPORE Grant Worth More Than $10 Million
http://www.medicalnewstoday.com/articles/120098.php
The <a href="http://www.cancer.gov/" target="_blank" rel="nofollow">National Cancer Institute</a> (NCI) has awarded <a href="http://www.moffitt.org/Site.aspx?spid=2201C678B0314C1D9C3EE72EEDF376A5&SearchType=Physician" target="_blank" rel="nofollow">Dr.
U.S. Phase 2 Combination Clinical Trial For Non-Small Cell Lung Cancer Patients With K-RAS Or EGFR-Activated Tumours
http://www.medicalnewstoday.com/articles/120035.php
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
VCU Massey Cancer Center Spearheads Novel Clinical Study For Lymphoma Patients
http://www.medicalnewstoday.com/articles/120123.php
The Virginia Commonwealth University Massey Cancer Center recently opened a National Cancer Institute (NCI)-sponsored, phase II clinical study for certain sub-types of non-Hodgkin's lymphoma.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
ProsCan For Men: Randomised Controlled Trial Of A Decision Support Intervention For Men With Localised Prostate Cancer
http://www.medicalnewstoday.com/articles/120023.php
UroToday.com - With advances in treatment for prostate cancer and the often deleterious side-effects of treatment, newly diagnosed men are faced with difficult treatment decisions. For men with localised disease, the complexity of treatment decision-making is enhanced by the notion that some tumours are indolent in nature and therefore unlikely to ever cause clinical concern or death if left untreated.
Scientists Find Second Site For Prostate Cancer Gene
http://www.medicalnewstoday.com/articles/120017.php
Scientists at Wake Forest University School of Medicine and colleagues who are studying a prostate cancer gene called HNF1B have found a second independent site within the HNF1B gene on chromosome 17 (17q12) increasing the number of genetic variants that may contribute to risk of developing the disease.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment